期刊文献+

抗结核药物及方案对结核性脑炎治疗作用及药物的药代动力学/药效学研究 被引量:10

Study on therapeutic effect of anti-TB drugs and regimens for tuberculosis meningitis and PK/PD of these drugs
原文传递
导出
摘要 目的测定三种抗结核药在健康和结核性脑膜炎小鼠脑组织中的浓度,评价几种单药和联合方案抗肺结核和结核性脑膜炎的活性;评价其药代动力学/药效学(PK/PD)参数。方法通过小鼠静脉感染H37Rv建立结核性脑膜炎模型,健康和结核性脑膜炎小鼠分别连续给予利福平(RFP)、左氧氟沙星(Lfx)、莫西沙星(Mfx)5d后,于不同的时间点取血和脑组织样本,HPLC法测定药物浓度,计算PK及PK/PD参数;结核性脑膜炎小鼠以常用于结核性脑膜炎治疗的几种抗结核药单药和Lfx、Mfx以及几种联合方案进行治疗,于给药56d后进行肺、脑活菌计数,应用单因素方差分析,比较各药及化疗方案抗肺结核和结核性脑膜炎活性;并结合PK/PD参数进行评价。结果结核性脑膜炎小鼠的脑组织中RFP、Lfx、Mfx的AUC0-24分别增加56.0%、148.5%、80.4%;AUC0-24/MIC分别为445.0、16.5、7.4;各组治疗8周后,对肺结核的治疗除吡嗪酰胺(PZA)、Lfx以外,均有显著疗效;对结核性脑膜炎的治疗,除Lfx组以外,均有显著疗效,且异烟肼(INH)、PZA、丙硫异烟胺(Pto)、RFP+INH+Pto(RHPto)、RFP+INH+Lfx(RHLfx)、RFP+INH+Mfx(RHMfx)各组有非常显著的疗效,与空白对照组相比分别下降1.87、1.26、0.97、1.42、1.31、1.33、1.32log10CFU。结论结核性脑膜炎小鼠的脑组织药量相比健康小鼠有显著增加;依据结核性脑膜炎患者的不同情况,可以选用这几种联合化疗方案进行治疗。 Objective To determinte the concentrations of three anti-TB drugs are increased in the brain tissue of health and TB meningitis(MTB) model mice,study the pharmacokinetics/pharmacodynamics (PK/PD) parameters of them in plasma and brain tissue using healthy and MTB model mice,evaluate the activities of these drugs respectively and combinations of them,provide information for the treatment of MTB based on their activities and parameters.Methods MTB mice model was developed through injecting H37Rv into the tail vein of mice.After administrated RFP,Lfx,Mfx for 5 days,the plasma and brain tissue of healthy and MTB mice were gotten at different time points and the concentrations of these drugs were determined by HPLC,and then obtain the PK and PK/PD parameters.The mice were given Lfx,Mfx and other drugs usually used to therapy TB alone or combination,CFU in lungs and brain tissues were obtained after treatment for 8 weeks and these data together with the PK and PK/PD parameters were analyzed to evaluate the efficiency of treating pulmonary TB and MTB.Results The AUC0-24 of RFP,Lfx,Mfx were increased by 56.0%,148.5%,80.4%,AUC0-24/MIC were 445.0,16.5,7.4 respectively;after treatment for 8 weeks,except PZA,Lfx that the CFU were decreased more.For MTB,every groups except Lfx were effective and INH,RHPto,RHLfx,RHMfx were more effective.Conclusions The amounts of drugs entering into the brain tissue increase while the brain was infected by H37Rv when compared with that of healthy mice;RHPto,RHLfx,RHMfx are effective combinations to therapy MTB,so all of them can be choosed as therapeutic remedy for different patients.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第5期73-78,共6页 Chinese Journal of Clinicians(Electronic Edition)
关键词 结核 脑膜 血脑屏障 色谱法 高压液相 集落计数 微生物 药代动力学/ 药效学 Tuberculosis, meningeal Blood-brain barrier Chromatography, high pressureliquid Colony count,microbial PK/PD
  • 相关文献

参考文献10

  • 1Be NA,Lamichhane G,Grosset J,et al.Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system.J Infect Dis,2008,198:1520-1528.
  • 2Alffenaar JW,van Altena R,B(o)kkerink HJ,et al.Pharmacokinetics of moxifloxacin in cerebrospinal fluid plasma in patients with tuberculosis meningitis.Clin Infect Dis,2009,49:1080-1082.
  • 3Alffenaar JW,de Vires PM,Luijckx GJ,et al.Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculosis meningitis.Antimicrob Agents Chemother,2008,52:2293-2295.
  • 4Thwaites GE,Tran TH.Tuberculosis meningitis:many questions,too few answers.Lancet Neurol,2005,4:160-170.
  • 5陆宇,王彬,郑梅琴,赵伟杰,李芃.应用Alamar Blue和MTT测定抗结核药物最低抑菌浓度的研究[J].中国防痨杂志,2007,29(6):499-501. 被引量:37
  • 6Pardridge WM.Drug targeting to the brain.Pharm Res,2007,24:1733-1744.
  • 7Nuermberger E,Grosset J.Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.Eur J Clin Microbiol Infect Dis,2004,23:243-255.
  • 8Davies GR,Nuermberger EL.Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs.Tuberculosis(Edinb),2008,88 Suppl 1:S65-74.
  • 9Wu HS,Kolonoski P,Chang YY,et al.Invasion of the brain and chronic centeral nervous system infection after system Mycobacterium avium complex infection in mice.Infect Immun,2000,68:2979-2984.
  • 10初乃惠,黄学锐.氟喹诺酮类药物在结核病治疗中的应用[J].中华临床医师杂志(电子版),2010,4(7):905-907. 被引量:26

二级参考文献18

  • 1黄学锐,高微微,卜建玲,戈启平,马玙.69例耐多药肺结核个体化治疗的疗效分析[J].中国防痨杂志,2004,26(5):257-260. 被引量:13
  • 2马玙,黄学锐.喹诺酮类药物的抗结核作用[J].中国医院用药评价与分析,2004,4(5):305-306. 被引量:12
  • 3盛大平,徐元宏.alamarBlue在临床检验中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(6):367-368. 被引量:13
  • 4[1]Martin A,Morcillo N,Lemus D,et al.Multicenter study of MTT and Resazurin assays for testing susceptility to first-line anti-tuberculosis drugs[J].Int J Tuberc Lung Dis,2005,9 (8):901-906
  • 5[3]Yajko D M,Madej J J,Lancaster M V,et al.Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.[J].J Clin Microbiol,1995,33:2324-2327
  • 6[4]Collins L A,Franzblau S G.Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium[J].Antimicrobial Agents Chemother,1997,41 (5):1004-1009
  • 7Hu Y;Coates AR;Mitchison DA.Sterilizing activities of fluoroquinolonesagainst rifampin-tolerant populations of Mycobacterium tuberculosis[J],2003(02).
  • 8WHO.Guidelines for the programmztic management of drug-resistant tuberculosis[WHO/HTM/TB/2008.402],2008.
  • 9Yew WW;Chan CK;Leung CC.Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis:preliminary results of a retrospective study from Hong Kong[J],2003(04).
  • 10Maranetra KN.Quinolones and multidrug-resistant tuberculosis[J]Suppl ,1999(2).

共引文献61

同被引文献114

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部